AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05157880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovering Together
Description: In the skills-based intervention group, sessions focus on developing skills to cope and manage ANI related stressors. The intervention will be tailored consistent with AHA recommendations for ANI skills-based interventions and will include 2 general and 4 specific modules. It is anticipated that the intervention will have 6 sessions with 2 general sessions delivered, in person if possible, within the NICU, or through live video using Zoom if patients leave the hospital before sessions occur, and 4 tailored specific sessions (chosen from by the dyads from 6 available modules) to be delivered via live video using Zoom.
Study NCT05157880 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Recovering Together
Description: Those in the educational program will receive general health information that mimics the skills-based intervention, but without teaching any of the resiliency or interpersonal communication skills that are hypothesized to be responsible for improvement in emotional distress. There will also be 6 sessions, 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits following discharge. The educational program group will not have the opportunity to specify which modules they would like to take; the modules will be predetermined. All participants will receive medical care as determined by their medical team.
Study NCT05994547 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Byfavo
Description: For induction and maintenance of sedation
Study NCT05994547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: For induction and maintenance of sedation
Study NCT05354518 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: gestational diabetes management of midwifery students
Description: Gestational diabetes management of midwifery students with a simulator
Study NCT05357534 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Physical activity: 10 km run on a treadmill
Study NCT05357534 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Description: Physical activity: 10 km run on a treadmill
Study NCT05028764 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Buccal Swabs, Blood Draws and Skin Punch Biopsy
Description: Buccal Swabs - FXN and specific RNA markers; Blood Draws - Lipid panel, Protein Marker Analysis and Gene RNA Analysis; Skin Punch Biopsy - Protein Markers
Study NCT05260177 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Light Therapy System (LTS): Active Setting
Description: Exposure for 1 hour á day for consecutive days
Study NCT05260177 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Light Therapy System (LTS): Sham Setting
Description: Exposure for 1 hour á day for consecutive days
Study NCT06223295 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Focal therapy
Description: Focal therapy selectively treats a specific part of the prostate while preserving the rest of the gland in men with prostate cancer.~Focal therapy with ultrasound ablation (HIFU/TULSA) or irreversible electroporation (IRE) followed by an intensive MRI follow-up scheme at 12, 24, 36, 48 and 60 months, prostate biopsy at 12 months (and also when indicated) and PSA monitoring
Study NCT06223295 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: standard radical treatment; prostatectomy or radiotherapy with follow-up according international guidelines (PSA monitoring and imaging when indicated).
Study NCT06070090 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: The traditional East Asian methods of treating disease by inserting needles along specific pathways or meridians.
Study NCT05254080 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active taVNS
Description: Electrodes will be attached to the participant's ear with a small sticker or clip, which will deliver mild stimulation. These electrodes will be plugged into the Digitimer DS7a device, which is a device that delivers transcutaneous auricular vagus nerve stimulation or taVNS. Stimulation will be delivered randomly to participant's tragus (the small cartilage knob before the ear canal) for up to 5 minutes while you participate in the stress induction test (by putting both feet into an ice bath).
Study NCT05254080 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham taVNS
Description: Electrodes will be attached to the participant's ear with a small sticker or clip, which will deliver mild stimulation. These electrodes will be plugged into the Digitimer DS7a device, which is a device that delivers transcutaneous auricular vagus nerve stimulation or taVNS. Stimulation will be delivered randomly to participant's tragus (the small cartilage knob before the ear canal) for up to 5 minutes while you participate in the stress induction test (by putting both feet into an ice bath). During sham (placebo) stimulation, ear electrodes will be attached to the participant's ear but they will not receive any stimulation.
Study NCT05920499 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: AUDIT and Feedback
Description: AUDIT and Feedback is a well-known quality intervention that according to the last Cochrane review leads to small but potentially important improvements in professional practice (Ivers N et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, 6:Cd000259).~Standardized automated AUDITs are available in most EHR systems in Belgium. Feedback, on the other hand, is only available in specific registration networks. At study baseline the performance in INTEGO practices will be measured. Afterwards a standardized clinical AUDIT to identify patients that may benefit from pneumococcal vaccination will be implemented in the EHR of all INTEGO practices. The Feedback will only be implemented in the intervention group.
Study NCT05920499 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AUDIT and Feedback
Description: AUDIT and Feedback is a well-known quality intervention that according to the last Cochrane review leads to small but potentially important improvements in professional practice (Ivers N et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, 6:Cd000259).~Standardized automated AUDITs are available in most EHR systems in Belgium. Feedback, on the other hand, is only available in specific registration networks. At study baseline the performance in INTEGO practices will be measured. Afterwards a standardized clinical AUDIT to identify patients that may benefit from pneumococcal vaccination will be implemented in the EHR of all INTEGO practices. The Feedback will only be implemented in the intervention group.
Study NCT04607902 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive Therapy SSI
Description: Online, 30-minute self-administered program for youth
Study NCT04607902 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation SSI
Description: Online, 30-minute self-administered program for youth
Study NCT04607902 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Growth Mindset SSI
Description: Online, 30-minute self-administered program for youth
Study NCT05304845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP14012
Description: Potassium-competitive acid blocker
Study NCT05304845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: acetylsalicylic acid
Study NCT05488951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program
Description: The Otago Exercise Program will be led by a physical therapist in a group setting (5-7 participants/exercise class). The exercise will be 20 min of walking and 30 min of strength and balance exercises (i.e., 50 min exercise class) 3x/week for 6 months. The physical therapist will select suitable exercises for each participant, such that the exercise is individualized and progressive.
Study NCT04739033 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: VIVIR MEJOR EXPERIMENTAL
Description: This group will receive access to the web-based lifestyle intervention (exercise and nutritional education), supported by audiovisual instructions given by their hypertension specialist doctor.~The self-applied online program will comprise a three months behavioural intervention composed by 9 modules seeking to develop gradually achieving the goals of changing eating and physical activity habits, supported by audiovisual instructions. This group will receive access to the web-based lifestyle intervention (exercise and nutritional education), supported by audiovisual instructions given by their hypertension specialist doctor.
Study NCT04739033 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VIVIR MEJOR EXPERIMENTAL
Description: This group will receive access to the web-based lifestyle intervention (exercise and nutritional education), supported by audiovisual instructions given by their hypertension specialist doctor.~The self-applied online program will comprise a three months behavioural intervention composed by 9 modules seeking to develop gradually achieving the goals of changing eating and physical activity habits, supported by audiovisual instructions. This group will receive access to the web-based lifestyle intervention (exercise and nutritional education), supported by audiovisual instructions given by their hypertension specialist doctor.
Study NCT04777760 — intervention group
Intervention type: DRUG
Intervention: one dose of surfactant replacement
Description: the preterm infants diagnosed with NRDS and/or NARDS will be administrated with only one dose of surfactant
Study NCT04777760 — intervention group
Intervention type: DRUG
Intervention: two and more doses of surfactant replacement
Description: the preterm infants diagnosed with NRDS and/or NARDS will be administrated with two and more doses of surfactant
Study NCT05867758 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychosocial group intervention
Description: The psychosocial group intervention is composed of 8 weekly sessions of 90 minutes each and the receiving of self-help digital materials. Both organized as following: 2 on isolation, loneliness and social connection, 2 on well-being, 2 on the use of digital tools, 2 on the fostering of socialization with peers.~To evaluate the effects of the blended intervention and of the two conditions we will ask participants to fulfill the following clinical questionnaires: ULS-6 (Russell et al. 1980), MSPSS (Zimet et al., 1988), GAD-7 (Spitzer et al., 2006), PHQ-9 (Kroenke, Spitzer \& Williams, 2001), SWLS (Diener et al., 1985), MLQ (Steger et al., 2006) before starting the intervention in presence and online (T0), at the end of that period (T1) and 2 months after (T2).
Study NCT05657366 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peritoneal lavage
Description: Continuous abdominal flushing with normal saline
Study NCT04733586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sonar guided fascia iliaca
Description: Sonar guided fascia iliaca
Study NCT04733586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sonar guided quadratus lumborum block
Description: Sonar guided quadratus lumborum block
Study NCT06145503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dance Intervention Group
Description: The dance sessions, tailored to participants' preferences, were accompanied by music from the 80s and 90s. A dance instructor demonstrated each dance step, and the sessions comprised a 10-minute warm-up, 40 minutes of dancing, and a 10-minute cool-down. The complexity and intensity of the dance routines were adjusted based on individual abilities, functional variations, and capacity.
Study NCT05053269 — intervention group
Intervention type: OTHER
Intervention: good body weight growth
Description: body weight growth after birth is consistent with the growth curve
Study NCT05053269 — intervention group
Intervention type: OTHER
Intervention: poor body weight growth
Description: body weight growth after birth is inconsistent with the growth curve
Study NCT05091983 — intervention group
Intervention type: OTHER
Intervention: Sensory Processing Scale Inventory (SPSI)
Description: The Sensory Processing Scale Inventory (SPSI) is the main questionnaire. It allows to define over and under sensitive profiles. It's a self-administrated questionnaire
Study NCT05091983 — intervention group
Intervention type: OTHER
Intervention: Autism Spectrum Screening Quotient (ASSQ)
Description: The ASSQ allows to detect autism spectrum disorders (ASD). This quotient is proposed to the group because the investigators know that ASD are often correlated with sensory integration disorders.~It's answered by the participant's parents.
Study NCT05091983 — intervention group
Intervention type: OTHER
Intervention: GAD 7
Description: The GAD7 questionnaire allows to detect anxiety disorder. This questionnaire is proposed to the group because the investigators know that anxiety disorders are often correlated with sensory integration disorders.~It's a self-administrated questionnaire.
Study NCT05091983 — intervention group
Intervention type: OTHER
Intervention: Conners abridged
Description: The Conners abridged questionnaire allows to detect attention-deficit hyperactivity disorder (ADHD). This questionnaire is proposed to the group because the investigators know that ADHD are often correlated with sensory integration disorders.~The questionnaire is answered by the participant's parents.
Study NCT05091983 — intervention group
Intervention type: OTHER
Intervention: EAT 26
Description: The EAT 26 questionnaire allows to detect anorexia nervosa. It is proposed to the patient with an eating disorder to establish the level of severity of their disease.~It's a self-administrated questionnaire.
Study NCT06415019 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen (BAYH006689)
Description: BAYH006689 gel will be dispensed directly on the patch
Study NCT06415019 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Gel
Description: Placebo gel will be dispensed directly on the patch
Study NCT06415019 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: A solution of 0.9% Saline
Description: 0.9% Saline will be dispensed directly on the patch.
Study NCT04609683 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AleriTM sensors
Description: AleriTM sensors are worn on the bicep or forearm and communicates through BLETM to a mobile App. The data is sent through the mobile App to web-based system processing where PHI is calculated and sent back to the mobile App.~The AleriTM sensor has a form factor similar to a conventional arm band, with a hockey puck shape of approximately 48mm in diameter and 15mm in thickness the AleriTM sensor is a non-significant risk (NSR) device as it does not meet the definition of significant risk device (21 CFR 812.3(m)) because it is: not an implant; is not purported or represented to support or sustain human life; its use is not of substantial importance in the diagnosis, cure, treatment, mitigation, or prevention of impairment of health; and it does not present a serious risk to the health, safety, or welfare of a subject.
Study NCT05537311 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Engagement
Description: 30-45 minutes of social engagement provided to patients in ICU. Social engagement strategies including meaningful conversation, cognitive stimulation, and emotional support
Study NCT05582278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-TACE
Description: CalliSpheres (100-300 µm) loaded with pirarubicin for transarterial chemombolization: Typically, one vial of the beads was loaded with 60 mg pirarubicin. If blushed tumors is still visible after the embolization with one vial of beads, regular microspheres (8spheres) with diameters of 100-700 μm are additionally injected.
Study NCT05582278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAIC
Description: FOLFOX-based regimen for hepatic arterial infusion chemotherapy: oxaliplatin, 100 mg/m2 infusion for 2 hours; calcium levofolinate, 200 mg/m2 infusion for 1 hours; and 5-FU, 400 mg/m2 bolus infusion and then 2400 mg/m2 continuous infusion over 46 h.
Study NCT05582278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: 12 mg/d for bodyweight ⩾ 60 kg or 8 mg/d for bodyweight \<60 kg
Study NCT05582278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tislelizumab
Description: tislelizumab 200 mg, every 3 weeks.
Study NCT06354218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serplulimab
Description: Serplulimab （4.5mg/Kg every 3 weeks）
Study NCT05627518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linaprazan glurate
Description: 100 mg
Study NCT05627518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linaprazan glurate
Description: 100 mg
Study NCT05185466 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-Supported Self Management Programme
Description: Training and incentives to improve nutrition habits and sleep health.
Study NCT04823312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental prospective single arm evaluating the Medtronic Duo Extended Set
Description: Subjects will be using 4 Duo extended sets that will serve as an exploratory pilot study to assess the 7-day survival of the Duo Extended set.
Study NCT05775627 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction
Description: Participants are randomized into either a group (n=10) that is sleep restricted first or control first (n=10) group; the groups will crossover halfway through the protocol. Both arms are fed 3 meals and have access to ad libitum food between meals. Both groups will also undergo up to 3 mixed-meal tolerance tests to measure glucose tolerance.
Study NCT04951089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: i-gel Supraglottic device insertion
Description: i-gel insertion for oxygenation
Study NCT04951089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air-Q SP 3G Supraglottic device insertion
Description: Air-Q SP 3G insertion for oxygenation
Study NCT06298955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OMS906 study drug
Description: OMS906 study drug repeat-dose 5mg/kg IV administration at 8-week intervals
Study NCT00105742 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Diagnosis
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthesia solution at room temperature
Description: The local anesthesia cartridge is used at room temperature (average of 21 °C)
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local anesthesia solution pre-warmed to 37°C
Description: About 150 ml of water at 21°C is added to the heating compartment of the heating device. The Local anesthesia cartridge is placed at the bottom of the heating compartment. The device is plugged in and the control gauge is set at the Express milk warming setting for contents up to 180ml/6oz mark. The contents would reach 37°C at 120 seconds.
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Local anesthesia solution pre-warmed to 40°C
Description: About 150 ml of water at 21°C is added to the heating compartment of the heating device. The Local anesthesia cartridge is placed at the bottom of the heating compartment. The device is plugged in and the control gauge is set at the Express milk warming setting for contents up to 180ml/6oz mark. The contents would reach 40°C at 130 seconds.
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Maxillary infiltration technique
Description: A 30 gauge short needle is oriented so that the bevel is facing the bone. The syringe is held parallel to the long axis of the tooth and the needle is inserted into the height of the mucobuccal fold over the offending tooth. The needle is advanced to a depth of 1 millimeter into the tissues. Aspiration is done, and once it is negative then 0.6 ml (nearly one third of the cartridge) of the anesthetic solution is injected slowly without permitting the tissues to balloon.
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Maxillary infiltration technique
Description: A 30 gauge short needle is oriented so that the bevel is facing the bone. The syringe is held parallel to the long axis of the tooth and the needle is inserted into the height of the mucobuccal fold over the offending tooth. The needle is advanced to a depth of 1 millimeter into the tissues. Aspiration is done, and once it is negative then 0.6 ml (nearly one third of the cartridge) of the anesthetic solution is injected slowly without permitting the tissues to balloon.
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Inferior alveolar nerve block technique
Description: While the mouth is opened as wide as possible, the index finger palpates the external oblique ridge reaching the Coronoid notch. A 27-gauge long dental needle will be used for injection. The needle will be directed between the two primary molars on the opposing side of the arch, penetrating the tissues at the point halfway between coronoid notch and the pterygomandibular raphe at the occlusal plane level or slightly lower.The needle is withdrawn 2mm to aspirate. Once negative aspiration is checked, the remainder of the solution is deposited slowly. Approximately 1.0 mL of LA will be delivered near the inferior alveolar nerve. The average depth of insertion is about 15mm, which is nearly two-thirds the needle length.